A Phase I Study Evaluating the Safety, Tolerability, and Pharmacokinetics of VVN432 Nasal Spray

Clinical trial NCT07259538 · RECRUITING

Trial details

NCT number: NCT07259538
Sponsor: VivaVision Biotech, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Rhinosinusitis (CRS)

Start date: 2025-11-06
Primary completion: 2026-07-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.